These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30439835)

  • 21. Pramipexole and Electroconvulsive Therapy in Treatment-Resistant Depression.
    Gauthier C; Souaiby L; Advenier-Iakovlev E; Gaillard R
    Clin Neuropharmacol; 2017; 40(6):264-267. PubMed ID: 29059135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A meta-analysis of electroconvulsive therapy efficacy in depression.
    Kho KH; van Vreeswijk MF; Simpson S; Zwinderman AH
    J ECT; 2003 Sep; 19(3):139-47. PubMed ID: 12972983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant efficacy of electroconvulsive therapy is associated with a reduction of the innate cellular immune activity in the cerebrospinal fluid in patients with depression.
    Kranaster L; Hoyer C; Aksay SS; Bumb JM; Müller N; Zill P; Schwarz MJ; Sartorius A
    World J Biol Psychiatry; 2018 Aug; 19(5):379-389. PubMed ID: 28714751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic review of left unilateral electroconvulsive therapy.
    Kellner CH; Farber KG; Chen XR; Mehrotra A; Zipursky GDN
    Acta Psychiatr Scand; 2017 Aug; 136(2):166-176. PubMed ID: 28422271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relapse prevention after index electroconvulsive therapy in treatment-resistant depression.
    Youssef NA; McCall WV
    Ann Clin Psychiatry; 2014 Nov; 26(4):288-96. PubMed ID: 25401716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: a systematic review and meta-analysis.
    Ren J; Li H; Palaniyappan L; Liu H; Wang J; Li C; Rossini PM
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():181-9. PubMed ID: 24556538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiomics and blood-based biomarkers of electroconvulsive therapy in severe and treatment-resistant depression: study protocol of the DetECT study.
    von Mücke-Heim IA; Pape JC; Grandi NC; Erhardt A; Deussing JM; Binder EB
    Eur Arch Psychiatry Clin Neurosci; 2024 Apr; 274(3):673-684. PubMed ID: 37644215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electroconvulsive therapy for treatment-resistant depression.
    Hsieh MH
    Prog Brain Res; 2023; 281():69-90. PubMed ID: 37806717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: clinical efficacy.
    Sienaert P; Vansteelandt K; Demyttenaere K; Peuskens J
    J Affect Disord; 2009 Jul; 116(1-2):106-12. PubMed ID: 19081638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis.
    UK ECT Review Group
    Lancet; 2003 Mar; 361(9360):799-808. PubMed ID: 12642045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Psychiatric polypharmacy and electroconvulsive therapy in treatment-resistant depression].
    Zöllner R; Huber MT; Mangelsdorf C; Konrad C; Zavorotnyy M
    Nervenarzt; 2020 Jul; 91(7):624-634. PubMed ID: 31489462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of ketamine in electroconvulsive therapy.
    Kucia K; Merk W
    Psychiatr Pol; 2015; 49(6):1255-63. PubMed ID: 26909400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electroconvulsive therapy and autobiographical memory in patients with treatment-resistant depression.
    Napierała M; Bodnar A; Chlopocka-Wozniak M; Permoda-Osip A; Rybakowski J
    Psychiatr Pol; 2019 Jun; 53(3):589-597. PubMed ID: 31522199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy.
    Minelli A; Maffioletti E; Bortolomasi M; Conca A; Zanardini R; Rillosi L; Abate M; Giacopuzzi M; Maina G; Gennarelli M; Bocchio-Chiavetto L
    Acta Psychiatr Scand; 2014 Jun; 129(6):461-6. PubMed ID: 23957507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impacts of switching antidepressants after successful electroconvulsive therapy on the maintenance of clinical remission in patients with treatment-resistant depression: a chart review.
    Nakajima S; Ishida T; Akaishi R; Takahata K; Kitahata R; Uchida H; Suzuki T; Takeuchi H; Nomura K; Nakagawa A; Watanabe K; Kashima H
    J ECT; 2009 Sep; 25(3):178-81. PubMed ID: 19710625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).
    Kellner CH; Knapp RG; Petrides G; Rummans TA; Husain MM; Rasmussen K; Mueller M; Bernstein HJ; O'Connor K; Smith G; Biggs M; Bailine SH; Malur C; Yim E; McClintock S; Sampson S; Fink M
    Arch Gen Psychiatry; 2006 Dec; 63(12):1337-44. PubMed ID: 17146008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Executive function in treatment-resistant depression before and after electroconvulsive therapy.
    Stojanovic Z; Andric S; Soldatovic I; Dolic M; Spiric Z; Maric NP
    World J Biol Psychiatry; 2017 Dec; 18(8):624-632. PubMed ID: 27072874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Electroconvulsive therapy in treatment resistant depression: What is new?].
    Kaliora SC
    Psychiatriki; 2021 Dec; 32(Supplement I):82-89. PubMed ID: 34990383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of continuation and maintenance electroconvulsive therapy (c/m ECT) in the treatment of patients with therapy-resistant affective disorders: a retrospective analysis].
    Post T; Kemmler G; Krassnig T; Brugger A; Hausmann A
    Neuropsychiatr; 2015; 29(3):133-8. PubMed ID: 26092747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depression severity in electroconvulsive therapy (ECT) versus pharmacotherapy trials.
    Kellner CH; Kaicher DC; Banerjee H; Knapp RG; Shapiro RJ; Briggs MC; Pasculli RM; Popeo DM; Ahle GM; Liebman LS
    J ECT; 2015 Mar; 31(1):31-3. PubMed ID: 24839981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.